IGM BIOSCIENCES INC.

IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma

02 ноя 2022 15:05:01 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at Three Upcoming Investor Conferences

06 сен 2022 06:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2022 Financial Results and Provides Corporate Update

08 авг 2022 15:10:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2022 Jefferies Healthcare Conference

01 июн 2022 06:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the 2022 RBC Capital Markets Global Healthcare Conference

10 май 2022 06:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces First Quarter 2022 Financial Results and Provides Corporate Update

09 май 2022 15:16:43 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi

06 май 2022 06:00:00 Источник Nasdaq GlobeNewswire

IGM Announces Closing of $230.0 Million Public Offering

06 апр 2022 15:39:52 Источник Nasdaq GlobeNewswire

IGM Announces Pricing of $200.0 Million Public Offering

29 мар 2022 23:56:16 Источник Nasdaq GlobeNewswire

IGM Announces Proposed Public Offering

29 мар 2022 06:41:04 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

29 мар 2022 05:01:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast Today to Discuss Global Collaboration Agreement with Sanofi

29 мар 2022 01:00:03 Источник Nasdaq GlobeNewswire

IGM Biosciences Advances Novel Antibody IGM-6268 Into Clinical Trials for the Treatment and Prevention of COVID-19

09 фев 2022 06:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim 2022 Oncology Conference

03 фев 2022 15:05:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

05 янв 2022 06:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences Presents Clinical Data from IGM-2323 in Patients with Advanced B Cell Malignancies at 2021 American Society of Hematology Annual Meeting

11 дек 2021 12:31:32 Источник Nasdaq GlobeNewswire

IGM Biosciences to Collaborate on the Study of IgM and IgA Antibodies for the Prevention of Malaria

08 дек 2021 06:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 63rd Annual ASH Meeting

06 дек 2021 15:05:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies London Healthcare Conference

10 ноя 2021 15:05:02 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference

08 ноя 2021 06:00:01 Источник Nasdaq GlobeNewswire